Ralimetinib
- Generic Name
- Ralimetinib
- Drug Type
- Small Molecule
- Chemical Formula
- C24H29FN6
- CAS Number
- 862505-00-8
- Unique Ingredient Identifier
- 73I34XW4HD
- Background
Ralimetinib has been used in trials studying the treatment of Postmenopausal, Advanced Cancer, Adult Glioblastoma, Fallopian Tube Cancer, and Metastatic Breast Cancer, among others.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath